These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 10201255

  • 1. [Onchocerciasis].
    Takeuchi T.
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):455-7. PubMed ID: 10201255
    [No Abstract] [Full Text] [Related]

  • 2. Eotaxin expression in Onchocerca volvulus-induced dermatitis after topical application of diethylcarbamazine.
    Pearlman E, Toé L, Boatin BA, Gilles AA, Higgins AW, Unnasch TR.
    J Infect Dis; 1999 Oct; 180(4):1394-7. PubMed ID: 10479181
    [Abstract] [Full Text] [Related]

  • 3. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    Greene BM, Taylor HR, Cupp EW, Murphy RP, White AT, Aziz MA, Schulz-Key H, D'Anna SA, Newland HS, Goldschmidt LP.
    N Engl J Med; 1985 Jul 18; 313(3):133-8. PubMed ID: 3892293
    [Abstract] [Full Text] [Related]

  • 4. [An itching disease from the tropics: onchocerciasis as an imported disease].
    de Vries PJ, Kingma WP, Wetsteyn JC.
    Ned Tijdschr Geneeskd; 1994 Sep 03; 138(36):1793-8. PubMed ID: 7935904
    [No Abstract] [Full Text] [Related]

  • 5. Onchocerciasis in a teenager from Africa.
    Leake JA, Pong AL, Scher CA, Newbury RO, Cunningham BB.
    Arch Dermatol; 2004 Sep 03; 140(9):1161-6. PubMed ID: 15381564
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of onchocerciasis with ivermectin (Province of Bururi, Burundi): parasitologic and clinical evaluation of different periodicities of treatment.
    Vyungimana F, Newell E.
    Am J Trop Med Hyg; 1998 Nov 03; 59(5):828-31. PubMed ID: 9840606
    [Abstract] [Full Text] [Related]

  • 7. The burden of Onchocerca volvulus in Sudan.
    Mukhtar MM, Khier MM, Baraka OZ, Homeida MM.
    Ann Trop Med Parasitol; 1998 Apr 03; 92 Suppl 1():S129-31. PubMed ID: 9861278
    [Abstract] [Full Text] [Related]

  • 8. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
    Winnen M, Plaisier AP, Alley ES, Nagelkerke NJ, van Oortmarssen G, Boatin BA, Habbema JD.
    Bull World Health Organ; 2002 Apr 03; 80(5):384-91. PubMed ID: 12077614
    [Abstract] [Full Text] [Related]

  • 9. Recent updates on onchocerciasis: diagnosis and treatment.
    Udall DN.
    Clin Infect Dis; 2007 Jan 01; 44(1):53-60. PubMed ID: 17143815
    [Abstract] [Full Text] [Related]

  • 10. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
    Cupp EW, Cupp MS.
    Am J Trop Med Hyg; 2005 Dec 01; 73(6):1159-61. PubMed ID: 16354830
    [Abstract] [Full Text] [Related]

  • 11. Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time.
    Evans DS, Unnasch TR, Richards FO.
    Lancet; 2015 May 30; 385(9983):2151-2. PubMed ID: 26068266
    [No Abstract] [Full Text] [Related]

  • 12. Cutaneous onchocercoma.
    Okulicz JF, Stibich AS, Elston DM, Schwartz RA.
    Int J Dermatol; 2004 Mar 30; 43(3):170-2. PubMed ID: 15009384
    [Abstract] [Full Text] [Related]

  • 13. Community-based treatment of onchocerciasis with ivermectin in southwest Nigeria: dermatological response to a singledose therapy.
    Osungbade KO, Asuzu MC, Kale OO.
    Afr J Med Med Sci; 2001 Dec 30; 30(4):352-5. PubMed ID: 14510119
    [No Abstract] [Full Text] [Related]

  • 14. Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.
    Awadzi K, Opoku NO, Attah SK, Lazdins-Helds JK, Kuesel AC.
    Parasit Vectors; 2015 Oct 09; 8():515. PubMed ID: 26452723
    [Abstract] [Full Text] [Related]

  • 15. Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis.
    Kipp W, Bamhuhiiga J, Rubaale T, Büttner DW.
    Am J Trop Med Hyg; 2003 Dec 09; 69(6):621-3. PubMed ID: 14740878
    [Abstract] [Full Text] [Related]

  • 16. Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.
    Mackenzie CD, Geary TG.
    Expert Rev Anti Infect Ther; 2011 May 09; 9(5):497-501. PubMed ID: 21609260
    [No Abstract] [Full Text] [Related]

  • 17. [Short review of pathophysiology and therapeutic possibilities in onchocerciasis with reference to a case report].
    Winkler S, Wenisch C, Wiesinger E, Breyer S, Graninger W.
    Wien Klin Wochenschr; 1994 May 09; 106(11):354-8. PubMed ID: 8053203
    [Abstract] [Full Text] [Related]

  • 18. Ivermectin improves the skin condition and self-esteem of females with onchocerciasis: a report of two cases.
    Amazigo UV, Nnoruka E, Maduka C, Bump J, Benton B, Sékétéli A.
    Ann Trop Med Parasitol; 2004 Jul 09; 98(5):533-7. PubMed ID: 15257804
    [No Abstract] [Full Text] [Related]

  • 19. Onchocerciasis and dracunculosis.
    Elgart ML.
    Dermatol Clin; 1989 Apr 09; 7(2):323-30. PubMed ID: 2527659
    [Abstract] [Full Text] [Related]

  • 20. Subcutaneous nodules as a manifestation of onchocerciasis. A rare condition in the United States.
    Palomar JM, Bray DM, Grannis FW, Beaver PC.
    Arch Surg; 1976 Aug 09; 111(8):909-11. PubMed ID: 942304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.